CCCG-ALCL-2020 for Chinese Children and Adolescents With Newly Diagnosed High-risk ALCL | ClinicalTrials HQ

Ask about research services

Swipe the table sideways for more columns.

Trial	Conditions	Status	Phase	Updated	More info	NCT ID
CCCG-ALCL-2020 for Chinese Children and Adolescents With Newly Diagnosed High-risk ALCL	Hemic and Lymphatic Diseases, Neoplasms by Histologic Type, T-cell non-Hodgkin lymphoma, anaplastic large cell lymphoma, immune system disorder, immunoproliferative disorder, lymphatic system disorder, lymphoma, lymphoproliferative syndrome, neoplasm	Active, not recruiting	Phase 3	2026-03-19		NCT04881838

10 results · Page 1 of 1

Swipe the table sideways for more columns.

Organizations	Linked trials
Children's Cancer Group, China	8
Nanjing Children's Hospital	15
Qilu Hospital of Shandong University	249
Shanghai Children's Medical Center	33
Shenzhen Children's Hospital	16
Sun Yat-Sen Memorial Hospital of Sun Yat-Sen University	285
The First Affiliated Hospital of Zhengzhou University	203
Tianjin Cancer Hospital Airport Hospital	6
West China Second University Hospital	43
Xiangya Hospital	2

1 results · Page 1 of 1

Swipe the table sideways for more columns.

Research sites	City	Country	Linked trials
Shanghai Children's Medical Center	Shanghai	China	9